Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.35
Delayed Data
As of Jan 20
 -0.40 / -2.71%
Today’s Change
7.86
Today|||52-Week Range
17.25
-4.65%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Wheeler Craig A
President
Sale4/18/201626,608$9.69$257.8K+48.09%
Venkataraman Ganesh Kaundinya
Senior Vice President-Research
Buy1/09/201715,000$12.81$192.2K-11.69%
Venkataraman Ganesh Kaundinya
Senior Vice President-Research
Buy1/09/201724,647$7.41$182.6K-11.69%
Shea Richard P
Chief Financial Officer & Senior Vice President
Sale12/15/20167,733$15.00$116.0K-4.33%
Wheeler Craig A
President
Sale2/19/20167,875$9.37$73.8K+49.48%
Shapiro Bennett M
Director
Sale6/01/20165,200$13.00$67.6K+19.68%
Shapiro Bennett M
Director
Buy6/01/20165,200$12.90$67.1K+19.68%
Leicher Bruce A
General Counsel & Senior Vice President
Sale4/18/20166,206$9.69$60.1K+48.09%
Venkataraman Ganesh Kaundinya
Senior Vice President-Research
Sale4/18/20166,206$9.69$60.1K+48.09%
Shea Richard P
Chief Financial Officer & Senior Vice President
Sale4/18/20166,206$9.69$60.1K+48.09%
Page of 11